Enoximone
March 26, 2004 by admin · Leave a Comment
On March 25, 2004 Myogen Inc. announced preliminary results from its Phase III clinical trial of enoximone capsules. The 201 participants were patients with the most advanced stages of chronic heart failure who were dependent on intravenous (IV) inotrope therapy. The study was designed to evaluate enoximone capsules as an effective treatment to wean patients [...]
Daxas (roflumilast)
March 12, 2004 by admin · Leave a Comment
On March 12, 2004 Altana AG announced that it had presented strong data on its Chronic Obstructive Pulmonary Disease (COPD) drug roflumilast, also known as Daxas, at a German scientific meeting. Daxas, which is to be jointly marketed with Pfizer, has been filed for marketing approvals in Europe. Altana has said it hopes Pfizer will [...]